CardiaLen Investors

21 investors on Angel Roster list CardiaLen in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name CardiaLen can appear together.

Investors listed
21
With verified email
29%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 CardiaLen investors

The most complete profiles first. Showing 21 of 21.

  • Benjamin KreitmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedHR TechAndroid

    Portfolio: FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics and 39 more

    Verified email available

  • Christopher de SouzaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedEnterprise SoftwareHR Tech

    Portfolio: SecurEnds, FineHeart, Provasculon, Laurantis Pharma and 40 more

    Verified email available

  • Daniel GottliebVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedHR TechLife Science

    Portfolio: FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics and 39 more

    Verified email available

  • Tom NeedhamVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedHR TechAndroid

    Portfolio: FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics and 39 more

    Verified email available

  • Adam CohenVerified

    Venture Capital · United States

    Health CareWomen FoundedHR TechLife Science

    Portfolio: FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics and 39 more

    Verified email available

  • Eric MillerVerified

    Incubator, Accelerator · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Companion Pharma, Confluence Life Sciences, GeneriCo, SentiAR and 44 more

    Contact details available

  • Chris Colecchi

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedHR TechLife Science

    Portfolio: FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics and 39 more

    Contact details available

  • Derek Rapp

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Hewmun Lau

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedHR TechLife Science

    Portfolio: FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics and 39 more

    Contact details available

  • Isaac Zike Ph.D.

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Jay Schmelter

    Venture Capital, Founder, Private Equity Firm · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • John McKearn

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Karen Spilizewski

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Maria Berkman, MD, MBA

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedHR TechLife Science

    Portfolio: FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics and 39 more

    Contact details available

  • Nancy Hong, PhD

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 37 more

    Contact details available

  • Tom Melzer

    Venture Capital, Founder, Investor · United States

    Series BSeries AHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Charlie Bolten

    Incubator, Accelerator · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Companion Pharma, Confluence Life Sciences, GeneriCo, SentiAR and 44 more

    Contact details available

  • Daniel Broderick

    Venture Capital, Incubator, Entrepreneurship Program · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Companion Pharma, Confluence Life Sciences, GeneriCo, SentiAR and 44 more

    Contact details available

  • Eric Gulve

    Incubator, Accelerator · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Companion Pharma, Confluence Life Sciences, GeneriCo, SentiAR and 44 more

    Contact details available

  • William SchmidtVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    SeedBankingMarketplaceFinanceSoftware

    Portfolio: CardiaLen, BlueStrata EHR, Clever Real Estate

    Verified email available

  • Anthony Lamport

    Venture Capital · United States

    Enterprise SoftwareHR TechAppsLife Science

    Portfolio: SkillSurvey, DFMSim, CardiaLen, Hyperformix

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

  • Adarza BioSystems11
  • NuPulseCV8
  • Allosteros8
  • FineHeart8
  • Acesion Pharma8
  • Alleviant Medical8
  • 480 Biomedical8
  • Viridian Therapeutics8
  • Intravascular Imaging Incorporated8
  • DecImmune Therapeutics8
  • Remedy Pharmaceuticals8

Frequently asked questions

How many CardiaLen investors are on Angel Roster?

Angel Roster lists 21 CardiaLen investors. 6 of them (29%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (18), Private Equity Firms (10) and Startup Incubators (4). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do CardiaLen investors invest in?

Among those that list a stage, the most common are Seed (14), Pre-Seed (4) and Series A (1).

Where are CardiaLen investors based?

Most are based in the United States (21).

Which companies have CardiaLen investors backed?

The most-backed portfolio companies among them are Adarza BioSystems (11), NuPulseCV (8), Allosteros (8), FineHeart (8) and Acesion Pharma (8).

How do I contact CardiaLen investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.